It may be suggested that the decrease in IGF-1 and testosterone levels in patients with Dravet syndrome, observed in a cohort study performed by Eschbach et al. [20], may not be related to stiripentol administration. Here, IGF1 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.